CCCC

C4 THERAPEUTICS INC

Healthcare | Small Cap

-$0.18

EPS Forecast

$9.19

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.18

Revenue Forecast:

$9.19

EPS Surprise Forecast:

$0.020

Revenue Surprise Forecast:

$0

Post-release price volatility - High

Post-release Overnight Move:

±8.8%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

66%

Probability of beating revenue consensus:

57%

Probability of beating both EPS & revs consensus:

43%

Probability of missing both EPS & revs consensus:

20%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

0.93

Earnings volatility

EPS standard deviation:

$0.10

Revenue standard deviation:

$5

As % of share price:

3.44% EXTREME UNCERTAINTY

As % of market cap:

1.44% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.06

Revenue 95th %ile:

$15

EPS 75th %ile:

-$0.15

Revenue 75th %ile:

$11

EPS 25th %ile:

-$0.21

Revenue 25th %ile:

$8

EPS 5th %ile:

-$0.30

Revenue 5th %ile:

$4

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

39% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

92% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$30

Bid-ask per Share:

$0.01